The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1137766
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP99961957.0
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
08/12/1999
Grant date:
28/09/2005
EP Publication Date:
28/09/2005
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/01/2019
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
28/09/2005
EP B1 Publication Date:
28/09/2005
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
07/12/2019
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
15/04/2013
Name:
AbbVie Biotherapeutics Inc.
Address:
1500 Seaport Blvd., 94063, Redwood City, California, United States of America (US)
Historical Applicant/holder
From:
08/04/2011
To:
15/04/2013
Name:
ABBOTT BIOTHERAPEUTICS CORPORATION
Address:
1500 Seaport Blvd., 94063, Redwood City, California, United States of America (US)
From:
02/11/2009
To:
08/04/2011
Name:
FACET BIOTECH CORPORATION
Address:
1500 Seaport Blvd., 94063, Redwood City, California, United States of America (US)
From:
13/07/2006
To:
02/11/2009
Name:
PDL BioPharma, Inc.
Address:
34801 Campus Drive, 94555, Fremont, California, United States of America (US)
From:
28/09/2005
To:
13/07/2006
Name:
PROTEIN DESIGN LABS, INC.
Address:
34801 Campus Drive, 94555, Fremont, California, United States of America (US)
Domicile Holder
Name:
dr. ir. G.J.C. Verdijck c.s.
From:
28/09/2005
Address:
Octrooibureau Arnold & Siedsma
p/a Postbus 18558, 2502 EN, Den Haag, Netherlands (NL)
To:
Inventor
1
Name:
Rolf EHRHARDT
Address:
CA 94131, San Francisco, United States of America (US)
2
Name:
Kenneth HONG
Address:
CA 94530, El Cerrito, United States of America (US)
3
Name:
Cary QUEEN
Address:
CA 94024, Los Altos, United States of America (US)
Licensee
1
Name:
AbbVie Biotechnology Limited
From:
11/10/2012
Address:
Clarendon House 2, Church Street, HM 11, Hamilton, Bermuda (BM)
To:
2
Name:
AbbVie Inc.
From:
11/10/2012
Address:
1 North Waukegan Rod, 60064, North Chicago, Illinios, United States of America (US)
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
8
Bulletin Heading:
EP2
Journal edition number:
2005/12
Publication date:
01/12/2005
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
200539
Publication date:
28/09/2005
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
019401-A019401-1
Date Registered:
15/04/2013
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Klos Morel Vos & Schaap
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Licence
Change Kind/ Decision Type:
New licence registration
Deed Number:
LRFC-474A
Date Registered:
11/10/2012
License Effective Date:
11/10/2012
License Expiration Date:
Scope of License:
Not Exclusive
Journal Edition Number:
Text:
Indiening exclusieve licentie-overeenkomst op 11 oktober 2012 door Klos Morel Vos & Schaap te Amsterdam Licentiegever is Abbott Biotherapeutics Corporation te North Chicago, Illinios (US) Licentiehouders zijn AbbVie Inc. te North Chicago, Illinios (US) en AbbVie Biotechnology Limited te Hamilton (BM). Zie verder de akte.
Deed Status:
Country Code:
United States of America (US)
Updated License Number:
Terminated License Number:
Added Licensee(s)
1
Name:
AbbVie Biotechnology Limited
Address:
Clarendon House 2, Church Street, HM 11, Hamilton, Bermuda (BM)
2
Name:
AbbVie Inc.
Address:
1 North Waukegan Rod, 60064, North Chicago, Illinios, United States of America (US)